Navamedic ASA (OSL:NAVA)

Navamedic ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	48.64	74.16	37.29	38.04	55.3	52.62
Cash & Short-Term Investments	48.64	74.16	37.29	38.04	55.3	52.62
Cash Growth	-5.94%	98.89%	-1.97%	-31.21%	5.09%	32.93%
Accounts Receivable	46.81	43.3	45.59	38.04	39.46	31.36
Other Receivables	10.82	12.65	10.37	16.83	18.43	22.03
Receivables	57.64	55.94	55.96	54.87	98.51	90.99
Inventory	99.55	116.56	81.89	105.2	79.64	61.88
Prepaid Expenses	-	15.93	8.67	10.62	-	-
Other Current Assets	-	9.3	16.19	1.39	10.09	-0
Total Current Assets	205.83	271.88	200	210.12	243.54	205.49
Property, Plant & Equipment	10.94	6.19	8.74	9.75	7.12	8.31
Long-Term Investments	-	-	-	-	-	18.84
Goodwill	188.72	207.57	159.05	156.73	100.74	61.03
Other Intangible Assets	204.66	250.89	92.56	97.63	30.54	27.34
Long-Term Deferred Tax Assets	0.93	0.93	0.93	0.93	0.84	9.17
Other Long-Term Assets	3.59	-	-	-	-	-
Total Assets	619.81	741.75	467.48	507.32	382.77	330.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	57.54	90.63	50.27	68.3	65.57	70.53
Accrued Expenses	-	43.1	47.05	42.45	40.07	29.72
Current Portion of Long-Term Debt	31.43	40.69	35.44	51.07	13.62	9.75
Current Portion of Leases	2.4	2.52	2.87	2.45	1.87	1.84
Current Income Taxes Payable	2.79	6.03	5.2	8.15	4.71	10.71
Other Current Liabilities	47.58	4.75	-0	16.86	0.22	13.16
Total Current Liabilities	141.74	187.73	140.82	189.28	126.06	135.71
Long-Term Debt	141.43	165	78.57	95.48	38.37	29.24
Long-Term Leases	7.63	0.01	1.69	3.89	4.86	5.82
Long-Term Deferred Tax Liabilities	7.05	7.75	8.36	9.27	-	-
Other Long-Term Liabilities	33.76	47.18	21.36	3.99	3.76	8.17
Total Liabilities	331.6	407.67	250.8	301.91	173.05	178.94

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	17.75	17.75	13.07	12.84	12.75	12.1
Additional Paid-In Capital	314.46	314.46	198.24	192.58	190.41	165.83
Retained Earnings	-43.99	1.88	5.36	-0.02	6.56	-26.69
Comprehensive Income & Other	-	-	0	-0	-	-
Shareholders' Equity	288.21	334.08	216.67	205.4	209.72	151.24
Total Liabilities & Equity	619.81	741.75	467.48	507.32	382.77	330.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	182.89	208.22	118.57	152.89	58.72	46.64
Net Cash (Debt)	-134.25	-134.07	-81.29	-114.86	-3.42	5.98
Net Cash Growth	-	-	-	-	-	-64.41%
Net Cash Per Share	-5.64	-7.04	-4.65	-6.65	-0.20	0.36
Filing Date Shares Outstanding	23.99	23.98	17.66	17.35	17.23	16.35
Total Common Shares Outstanding	23.99	23.98	17.66	17.35	17.23	16.35
Working Capital	64.09	84.16	59.18	20.84	117.48	69.78
Book Value Per Share	12.01	13.93	12.27	11.84	12.17	9.25
Tangible Book Value	-105.17	-124.38	-34.94	-48.95	78.44	62.86
Tangible Book Value Per Share	-4.38	-5.19	-1.98	-2.82	4.55	3.85
Machinery	-	7.87	7.18	5.18	1.18	1.14

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error